American Journal of Critical Care Medicine | December 20, 2022
This position paper calls for widespread and accelerated adoption of a new asthma treatment using a combination of inhaled corticosteroids in the United States. This is important because it would reduce time between research and implementation of this treatment over the counter instead of prescription, reducing cost and increasing access, which aims to address health disparities and equity. This manuscript was published by the Lung Association Airways Clinical Research Centers.
Make a Donation
Your tax-deductible donation funds lung disease and lung cancer research, new treatments, lung health education, and more.